Latest Articles
New Process Could Identify High Risk of Developing Endometrial Cancer - Worldwide Cancer Research
New Process Could Identify High Risk of Developing Endometrial Cancer Worldwide Cancer Research
Published: March 23, 2026, 10:38 a.m.
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence - Nature
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence Nature
Published: March 23, 2026, 8:51 a.m.
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease - Baishideng Publishing Group
Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease Baishideng Publishing Group
Published: March 23, 2026, 8:02 a.m.
Endometrial receptivity, immune signals and timing: The invisible barriers to conception that may be labelled as unexplained - MSN
Endometrial receptivity, immune signals and timing: The invisible barriers to conception that may be labelled as unexplained MSN
Published: March 22, 2026, 4:08 a.m.
Is abnormal bleeding an early sign of endometrial cancer? | Tap to know more | Inshorts - Inshorts
Is abnormal bleeding an early sign of endometrial cancer? | Tap to know more | Inshorts Inshorts
Published: March 19, 2026, 10:07 p.m.
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com India
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com India
Published: March 19, 2026, 9 p.m.
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus - Investing.com
Oppenheimer reiterates Acrivon stock rating on endometrial cancer focus Investing.com
Published: March 19, 2026, 8:25 p.m.
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods - The Manila Times
CORRECTION: Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods The Manila Times
Published: March 19, 2026, 2:19 p.m.
Link copied to clipboard!